Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon

Journal of Virology

Volumn 70, Issue 9, 1996, Pages 6314-6322

  Flomenberg, Phyllis ^a,b,c   Piaskowski, Victoria ^b   Truitt, Robert L ^b   Casper, James T ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; EXPRESSION VECTOR; GENE THERAPY; HUMAN; HUMAN ADENOVIRUS; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029793258     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.9.6314-6322.1996     Document Type: Article

References (49)

1. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and Z. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA, and other human cell surface antigens - new tools for genetic analysis. Cell 14:9-20.
2. Beier, D. C., J. H. Cox, D. R. Vining, P. Cresswell, and V. H. Engelhard. 1994. Association of human class 1 MHC alleles with the adenovirus E3/19K protein. J. Immunol. 154:3862-3872.
3. Bhat, B. M., and W. S. M. Wold. 1987. A small deletion distant from a splice or polyadenylation site dramatically alters pre-mRNA processing in region E3 of adenovirus. J. Virol. 61:3938-3945.
4. Brady, H. A., A. Scaria, and W. S. M. Wold. 1992. Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus. J. Virol. 66:5914-5923.
5. Brody, S. L., M. Metzger, C. Danel, M. A. Rosenfeld, and R. G. Crystal. 1994. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5:821-836.
6. Burgert, H., and S. Kvist. 1985. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41:987-997.
7. Chardonnet, Y., and S. Dales. 1970. Early events in the interaction of adenoviruses with HeLa cells. I. Penetration of type 5 and intracellular release of the DNA genome. Virology 40:462-477.
8. Cox, J. H., J. R. Bennink, and J. W. Yewdell. 1991. Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. J. Exp. Med. 174:1629-1637.
9. Cox, J. H., M. L. Buller, J. R. Bennink, J. W. Yewdell, and G. Karupiah. 1994. Expression of adenovirus E3/19K protein does not alter mouse MHC class I-restricted responses to vaccinia virus. Virology 204:558-562.
10. Del Val, M., H. Hengel, H. Hacker, U. Hartlaub, T. Ruppert, P. Lucin, and L. H. Koszinowski. 1992. Cytomegalovirus prevents antigen presentation blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J. Exp. Med. 172:729-738.
11. Engelhardt, J. F., Y. Yang, L. D. Stratford-Perricaudet, E. D. Allen, K. Kozarsky, M. Perricaudet, J. R. Yankaskas, and J. M. Wilson. 1993. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nature Genet. 4:27-34.
12. Engelhardt, J. F., X. Ye, B. Doranz, and J. M. Wilson. 1994. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91:6196-6200.
13. FitzGerald, D. J. P., R. Padmanabhan, I. Pastan, and M. C. Willingham. 1983. Adenovirus-induced release of epidermal growth factor and pseudomonas toxin into the cytosol of KB cells during receptor-mediated endocylosis. Cell 32:607-617.
14. Flomenberg, P., J. Babbitt, W. Drobjski, R. Ash, D. Carrigan, G. Sedmak, T. McAuliffe, B. Camitta, M. Horowitz, N. Bunin, and J. Casper. 1994. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J. Infect. Dis. 169:775-781.
15. Flomenberg, P., E. Gutierrez, and K. T. Hogan. 1994. Identification of class I MHC regions which bind to the adenovirus E3-19k protein. Mol. Immunol. 31:1277-1284.
16. Flomenberg, P., V. Piaskowski, R. L. Truitt, and J. T. Casper. 1995. Characterization of human proliferative T cell responses to adenovirus. J. Infect. Dis. 171:1090-1096.
17. Flomenberg, P. R., M. Chen, and M. S. Horwitz. 1987. Characterization of a major histocompatibility complex class I antigen-binding glycoprotein from adenovirus type 35, a type associated with immunocompromised hosts. J. Virol. 61:3665-3671.
18. Fox, J. P., C. E. Hall, and M. K. Cooney. 1977. The Seattle virus watch. VII. Observations of adenovirus infections. Am. J. Epidemiol. 105:362-386.
19. Gabathuler, R., G. Reid, G. Kolaitis, J. Driscoll, and W. A. Jefferies. 1994. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. J. Exp. Med. 180:1415-1425.
20. Germain, R. N., and L. R. Hendrix. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature (London) 353:134-139.
21. Grimm, E. A., R. J. Robb, J. A. Roth, L. M. Neckers, L. B. Lachman, D. F. Wilson, and S. A. Rosenberg. 1983. Lymphokine-actived killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activatcd killer cells. J. Exp. Med. 158: 1356-1361.
22. Hengel, H., P. Lucin, S. Jonjic, T. Ruppert, and U. H. Koszinowski. 1994. Restoration of Cytomegalovirus antigen presentation by gamma interferon combats viral escape. J. Virol. 68:289-297.
23. Horwitz, M. S. 1990. Adenoviruses, p. 1723-1740. In B. N. Fields, D. M. Knipe, R. M. Chanock, et al. (ed.), Fields virology, 2nd ed. Raven Press, New York.
24. Hromas, R., K. Cornetta, E. Srour, C. Blanke, and E. R. Broun. 1994. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. N. Engl. J. Med. 330:1689.
25. Kast, W. M., R. Offringa, P. J. Peters, A. C. Voordouw, R. H. Meloen, A. J. van der Eb, and C. J. M. Melief. 1989. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell 59:603-614.
26. Kelly, T. J., and A. M. Lewis, Jr. 1973. Use of nondefective adenovirussimian virus 40 hybrids for mapping the simian virus 40 genome. J. Virol. 12:643-652.
27. 2 microglobulin by interferon-γ. EMBO J. 8:475-481.
28. Korner, H., U. Fritzsche, and H. G. Burgert. 1992. Tumor necrosis factor a stimulates expression of adenovirus early region 3 proteins: implication for viral persistence. Proc. Natl. Acad. Sci. USA 89:11857-11861.
29. Kovacsovics-Bankowski, M., and K. L. Rock. 1995. A phagosom-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267:243-246.
30. Krilov, L. R., L. G. Rubin, M. Frogel, E. Gloster, K. Ni, M. Kaplan, and S. M. Lipson. 1990. Disseminated adenovirus infection with hepatic necrosis in patients with human immunodeficiency virus infection and other immunodeficiency states. Rev. Infect. Dis. 12:303-307.
31. Michaels, M. G., M. Green, E. R. Wal, and T. E. Starzl. 1992. Adenovirus infection in pediatric liver transplant recipients. J. Infect. Dis. 165:170-174.
32. Piaskowski, V. Unpublished data.
33. Rawle, F. C., B. B. Knowles, K. P. Ricciardi, V. Brahmacheri, P. Duerksen-Hughes, W. S. M. Wold, and L. R. Gooding. 1991. Specificity of the mouse cytotoxic T lymphocyte responses to adenovirus 5. J. Immunol. 146:3977-3984.
34. Rawle, F. C., A. E. Tollefson, W. S. H. Wold, and L. R. Gooding. 1989. Mouse anti-adenovirus cytotoxic T lymphocytes. J. Immunol. 143:2031-2037.
35. Riddell, S. R., M. Rabin, A. P. Geballe, W. J. Britt, and P. D. Greenberg. 1991. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. J. Immunol. 146:2795-2804.
36. Routes, J. M. 1992. IFN increases class I MHC antigen expression on adenovirus-infected human cells without inducing resistance to natural killer cell killing. J. Immunol. 149:2372-2377.
37. Sparer, T. E., R. A. Tripp, D. L. Dillehay, T. W. Hermiston, W. S. M. Wold, and L. R. Gooding. 1996. The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model. J. Virol. 70:2431-2439.
38. b-restricted SV40-specific CTL-mediated lysis. Virology 165:357-366.
39. + herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens. J. Virol. 66:1622-1634.
40. Walter, E. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038-1044.
41. Wilson-Rawls, J., S. K. Saha, P. Krajcsi, A. E. Tollefson, L. R. Gooding, and W. S. M. Wold. 1990. A 6700 MW membrane protein is encoded by region E3 of adenovirus type 2. Virology 178:204-212.
42. Wold, W. S. M., S. L. Deutscher, N. Takemoria, B. M. Bhat, and S. C. Magie. 1986. Evidence that AGUAUAUGA and CCAAGAUGA initiate translation in the same mRNA in region E3 of adenovirus. Virology 148:168-180.
43. Yang, Y., H. C. J. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-443.
44. Yang, Y., Q. Li, H. C. J. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
45. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
46. Yei, S., N. Mittereder, K. Tang, C. O'Sullivan, and B. C. Trapnell. 1994. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1:192-200.
47. Yewdell, J. W., and J. R. Bennink. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1-123.
48. York, I. A., C. Roop, D. W. Andrews, S. R. Riddell, F. L. Graham, and D. C. Johnson. 1994. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77:525-535.
49. Zabner, J., L. A. Couture, R. J. Gregory, S. M. Graham, A. E. Smith, and M. J. Welsh. 1993. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75:207-216.